Earnings

After a multi-month rally, shares of biotechnology firm ImmunityBio are experiencing a notable correction. Investor sentiment has been dampened by...

Oracle's latest quarterly earnings report delivered a powerful one-two punch: significant outperformance on key metrics, coupled with a bold and...

Take-Two Interactive is currently undergoing a significant corporate transition. Although the present fiscal year is projected to end with a...

A record-breaking quarter and explosive growth in artificial intelligence were not enough to prevent a sharp sell-off in Adobe shares....

Demonstrating formidable operational resilience after a brief February setback, Rocket Lab USA is currently showcasing its strategic execution. The aerospace...

Despite posting impressive quarterly results and announcing a significant new partnership, shares of AppLovin have recently faced notable selling pressure....

Analysts at CIBC have initiated coverage on Coeur Mining with a bullish "Outperformer" rating, setting a price target of $40...

Following a challenging fiscal 2025, evidence is mounting that Nike's operational performance may be improving. Upbeat sales figures from key...

The global food conglomerate Kraft Heinz is embarking on a critical and costly transformation. Under the leadership of its new...

Facing the impending loss of patent protection for its blockbuster drug Stelara in 2025, Johnson & Johnson has been under...